Aurobindo Pharma Ltd
NSE :AUROPHARMA BSE :524804 Sector : PharmaceuticalsBuy, Sell or Hold AUROPHARMA? Ask The Analyst
BSE
prev close
OPEN PRICE
bid price (qty)
offer price (qty)
volume
Today's low / high
52 WK low / high
NSE
prev close
open price
bid price (qty)
offer price (qty)
volume
Today's' low / high
52 WK low / high
24 Dec 1262.45 (0.76%) | 23 Dec 1252.95 (0.91%) | 20 Dec 1241.70 (-1.04%) | 19 Dec 1254.70 (0.57%) | 18 Dec 1247.55 (2.78%) | 17 Dec 1213.75 (-2.49%) | 16 Dec 1244.70 (3.00%) | 13 Dec 1208.40 (-0.51%) | 12 Dec 1214.60 (-0.92%) | 11 Dec 1225.85 (-0.91%) | 10 Dec 1237.10 (-0.19%) | 09 Dec 1239.50 (-0.54%) | 06 Dec 1246.20 (0.21%) | 05 Dec 1243.65 (-1.25%) | 04 Dec 1259.40 (-0.39%) | 03 Dec 1264.30 (0.76%) | 02 Dec 1254.75 (-0.62%) | 29 Nov 1262.60 (1.95%) | 28 Nov 1238.40 (1.23%) | 27 Nov 1223.40 (-0.33%) | 26 Nov 1227.45 (-1.15%) |
Price Chart Historical Data Technical Chart
Technical Analysis
Short Term Investors
Very Bullish
Medium Term Investors
Bearish
Long Term Investors
Neutral
Moving Averages
5 DMA
Bullish
1251.8
10 DMA
Bullish
1236.63
20 DMA
Bullish
1241.82
50 DMA
Bearish
1316.27
100 DMA
Bearish
1411.85
200 DMA
Bearish
1299.06
Intraday Support and Resistance
(Based on Pivot Points) |
Updated On Dec 24, 2024 04:00 PM For Next Trading Session
Pivots | Classic | Fibonacci | Camarilla | Woodie | DM |
---|---|---|---|---|---|
R3 | 1295.06 | 1282.08 | 1268.72 | - | - |
R2 | 1282.08 | 1273.37 | 1266.63 | 1282.88 | - |
R1 | 1272.26 | 1267.99 | 1264.54 | 1273.86 | 1277.18 |
P | 1259.28 | 1259.28 | 1259.28 | 1260.08 | 1261.74 |
S1 | 1249.46 | 1250.57 | 1260.36 | 1251.06 | 1254.38 |
S2 | 1236.48 | 1245.19 | 1258.27 | 1237.28 | - |
S3 | 1226.66 | 1236.48 | 1256.18 | - | - |
Key Metrics
EPS
35.31
P/E
35.75
P/B
3.76
Dividend Yield
0.36%
Market Cap
73,972 Cr.
Face Value
1
Book Value
335.47
ROE
11.18%
EBITDA Growth
1,701.44 Cr.
Debt/Equity
0.21
Shareholding History
Quarterly Result (Figures in Rs. Crores)
Aurobindo Pharma Ltd Quaterly Results
Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | ||
INCOME | 7407.3 | 7514.3 | 7715.77 | 7787.95 | 7932.37 | |
PROFIT | 757.18 | 936.29 | 974.2 | 919.22 | 817.38 | |
EPS | 12.83 | 16.04 | 15.51 | 15.69 | 14 |
Aurobindo Pharma Ltd Quaterly Results
Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | ||
INCOME | 2771.93 | 3023.16 | 3017 | 2525.41 | 2947.25 | |
PROFIT | 379.65 | 623.78 | 578.67 | 329.04 | 537.53 | |
EPS | 7.1 | 10.65 | 9.88 | 5.62 | 9.21 |
Profit & Loss (Figures in Rs. Crores)
Aurobindo Pharma Ltd Profit & Loss
Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | ||
INCOME | 12546.71 | 14092.78 | 15339.65 | 17050.67 | 20397.12 | 23392.24 | 29135.18 | 23075.19 | 25555.65 | 30505.42 | |
PROFIT | 1587.14 | 2028.78 | 2306.24 | 2423.17 | 2430.63 | 2864.68 | 3410.14 | 2757.17 | 1919.7 | 3272.95 | |
EPS | 26.48 | 34.58 | 38.88 | 41.35 | 40.36 | 48.54 | 91.04 | 45.18 | 32.9 | 54.09 |
Aurobindo Pharma Ltd Profit & Loss
Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | ||
INCOME | 8321.41 | 9496.13 | 9711.68 | 10684.73 | 12746.91 | 13998.23 | 16410.55 | 11912.62 | 9164.87 | 11431.97 | |
PROFIT | 1518.29 | 1627.51 | 1720.3 | 1812.82 | 1537.74 | 1878.78 | 3113.04 | 1535.98 | 1217.17 | 1952.97 | |
EPS | 25.54 | 27.8 | 28.73 | 30.94 | 26.11 | 32.03 | 53.13 | 24.83 | 20.94 | 33.35 |
Balance Sheet (Figures in Rs. Crores)
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | |
SOURCES OF FUNDS : | ||||||||||
Share Capital | 58.59 | 58.59 | 58.59 | 58.59 | 58.59 | 58.59 | 58.59 | 58.59 | 58.52 | 29.2 |
Reserves Total | 29,784.21 | 26,781.26 | 24,517.39 | 21,871.28 | 16,766.08 | 13,832.19 | 11,621.83 | 9,313.32 | 7,228.78 | 5,126.71 |
Total Shareholders Funds | 29,842.8 | 26,839.85 | 24,575.98 | 21,929.87 | 16,824.67 | 13,890.78 | 11,680.42 | 9,371.91 | 7,287.3 | 5,155.91 |
Minority Interest | 8 | 12 | -1.93 | -0.88 | 0.14 | 1.59 | 1.82 | 2.08 | 2.55 | 25.82 |
Secured Loans | 3,968.37 | 2,557.37 | 543.69 | 1,053.55 | 1,314.97 | 1,661.87 | 419.18 | 640.8 | 2,285.15 | 2,081.94 |
Unsecured Loans | 2,679.26 | 2,728.84 | 2,307.58 | 4,285.53 | 4,511.41 | 5,304.89 | 4,350.75 | 2,723.34 | 2,755.92 | 2,369.13 |
Total Debt | 6,647.63 | 5,286.21 | 2,851.27 | 5,339.08 | 5,826.38 | 6,966.76 | 4,769.93 | 3,364.14 | 5,041.07 | 4,451.07 |
Other Liabilities | 277.59 | 214.26 | 212.91 | 250.71 | 162.19 | 80.16 | 66.43 | 39.13 | 23.36 | 24.35 |
Total Liabilities | 36,776.02 | 32,352.32 | 27,638.23 | 27,518.78 | 22,813.38 | 20,939.29 | 16,518.6 | 12,777.26 | 12,354.28 | 9,657.15 |
APPLICATION OF FUNDS : | ||||||||||
Gross Block | 23,447.77 | 18,593.32 | 15,524.55 | 13,613.33 | 12,441.26 | 10,497.62 | 7,894.78 | 5,635.49 | 4,569.83 | 5,446.13 |
Less: Accumulated Depreciation | 8,954.98 | 7,569.63 | 4,992.46 | 4,239.75 | 3,044.79 | 2,022.77 | 1,374.1 | 801.71 | 390.14 | 1,740.49 |
Net Block | 14,492.79 | 11,023.69 | 10,532.09 | 9,373.58 | 9,396.47 | 8,474.85 | 6,520.68 | 4,833.78 | 4,179.69 | 3,705.64 |
Capital Work in Progress | 3,868.72 | 5,390.01 | 3,747.2 | 3,061.53 | 1,985.92 | 1,668.46 | 1,583.04 | 1,458.08 | 848.14 | 419.63 |
Investments | 372.23 | 542.74 | 997.15 | 591.01 | 554.71 | 360.22 | 311.54 | 245.87 | 122.96 | 19.79 |
Inventories | 9,810.47 | 8,516.11 | 7,559.08 | 9,041.18 | 7,699.87 | 7,245.6 | 5,858.41 | 4,330.54 | 4,056.14 | 3,611.3 |
Sundry Debtors | 4,816.74 | 4,466.38 | 4,012.26 | 3,503.28 | 4,315.16 | 3,413.78 | 3,080.2 | 2,765.33 | 4,606.68 | 3,539.17 |
Cash and Bank Balance | 6,278.3 | 6,084.2 | 4,190.01 | 5,474.28 | 2,842.15 | 1,957.18 | 1,262.25 | 513.48 | 800.26 | 469.11 |
Loans and Advances | 2,818.07 | 2,247.1 | 1,987.72 | 1,659.59 | 1,555.31 | 2,715.72 | 1,977.28 | 1,596.81 | 831.25 | 659.57 |
Total Current Assets | 23,723.58 | 21,313.79 | 17,749.07 | 19,678.33 | 16,412.49 | 15,332.28 | 12,178.14 | 9,206.16 | 10,294.33 | 8,279.15 |
Current Liabilities | 7,433.13 | 6,735.93 | 5,643.94 | 5,378.37 | 5,310.95 | 4,849.09 | 4,052.93 | 3,161.5 | 3,409.03 | 2,828.56 |
Provisions | 508.04 | 417.01 | 233.82 | 396.89 | 511.72 | 384.67 | 294.23 | 261.36 | 132.93 | 218.24 |
Total Current Liabilities & Provisions | 7,941.17 | 7,152.94 | 5,877.76 | 5,775.26 | 5,822.67 | 5,233.76 | 4,347.16 | 3,422.86 | 3,541.96 | 3,046.8 |
Net Current Assets | 15,782.41 | 14,160.85 | 11,871.31 | 13,903.07 | 10,589.82 | 10,098.52 | 7,830.98 | 5,783.3 | 6,752.37 | 5,232.35 |
Deferred Tax Assets | 1,335.71 | 768.88 | 429.74 | 600.91 | 163.2 | 183.29 | 539.17 | 501.82 | 227.37 | 33.3 |
Deferred Tax Liability | 479.63 | 481 | 552.11 | 722.79 | 291.69 | 281.31 | 615.65 | 383.36 | 45.05 | 239.08 |
Net Deferred Tax | 856.08 | 287.88 | -122.37 | -121.88 | -128.49 | -98.02 | -76.48 | 118.46 | 182.32 | -205.78 |
Other Assets | 1,403.79 | 947.15 | 612.85 | 711.47 | 414.95 | 435.26 | 348.84 | 337.77 | 268.8 | 485.52 |
Total Assets | 36,776.02 | 32,352.32 | 27,638.23 | 27,518.78 | 22,813.38 | 20,939.29 | 16,518.6 | 12,777.26 | 12,354.28 | 9,657.15 |
Contingent Liabilities | 311.34 | 158.53 | 157.74 | 140.83 | 145.98 | 133.71 | 211.79 | 196.97 | 177.11 | 195.38 |
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | |
SOURCES OF FUNDS : | ||||||||||
Share Capital | 58.59 | 58.59 | 58.59 | 58.59 | 58.59 | 58.59 | 58.59 | 58.59 | 58.52 | 29.2 |
Reserves Total | 19,664.23 | 17,975.44 | 17,058.75 | 15,866.02 | 12,993.91 | 11,292.03 | 9,923.99 | 8,377.59 | 6,807.33 | 5,330.34 |
Total Shareholders Funds | 19,722.82 | 18,034.03 | 17,117.34 | 15,924.61 | 13,052.5 | 11,350.62 | 9,982.58 | 8,436.18 | 6,865.85 | 5,359.54 |
Secured Loans | 1,431.99 | 1,922.78 | 288.75 | 841.5 | 1,314.36 | 1,594.43 | 376.19 | 498.65 | 1,002.71 | 1,884.01 |
Unsecured Loans | 1,428.75 | 2,280.38 | 1,606.14 | 3,200.46 | 2,427.1 | 2,925.37 | 3,342.81 | 2,555.26 | 3,162.72 | 1,400.72 |
Total Debt | 2,860.74 | 4,203.16 | 1,894.89 | 4,041.96 | 3,741.46 | 4,519.8 | 3,719 | 3,053.91 | 4,165.43 | 3,284.73 |
Other Liabilities | 46 | 87.31 | 5.03 | 0 | 42.68 | 22.64 | 33.6 | 20.87 | 21.26 | 22.65 |
Total Liabilities | 22,629.56 | 22,324.5 | 19,017.26 | 19,966.57 | 16,836.64 | 15,893.06 | 13,735.18 | 11,510.96 | 11,052.54 | 8,666.92 |
APPLICATION OF FUNDS : | ||||||||||
Gross Block | 4,043.49 | 6,214.71 | 5,724.9 | 6,688.9 | 6,180.91 | 5,446.15 | 4,292.18 | 3,758.18 | 2,830.78 | 3,507.54 |
Less : Accumulated Depreciation | 1,624.36 | 2,527.21 | 2,139.07 | 2,216.83 | 1,763.11 | 1,296.45 | 899.21 | 546.56 | 262.65 | 1,317.53 |
Net Block | 2,419.13 | 3,687.5 | 3,585.83 | 4,472.07 | 4,417.8 | 4,149.7 | 3,392.97 | 3,211.62 | 2,568.13 | 2,190.01 |
Capital Work in Progress | 132.68 | 239.09 | 225.15 | 734.89 | 814.85 | 789.01 | 1,143.98 | 906.98 | 742.14 | 227.19 |
Investments | 13,393.44 | 8,105.37 | 6,584.36 | 5,009.93 | 2,527.41 | 2,339.06 | 1,967.5 | 1,681.95 | 1,183.35 | 1,012.75 |
Inventories | 2,367.6 | 4,125.26 | 3,356.18 | 4,841.38 | 4,359.57 | 3,971.26 | 3,409.23 | 2,433.62 | 2,431.6 | 2,145.05 |
Sundry Debtors | 3,776.59 | 4,560.26 | 3,973.24 | 5,928.01 | 5,785 | 5,232.07 | 4,468.23 | 3,773.63 | 4,380.97 | 3,708.94 |
Cash and Bank Balance | 94.34 | 373.41 | 50.78 | 386.18 | 86.16 | 75.77 | 245.9 | 33.64 | 330.81 | 11.13 |
Loans and Advances | 1,000.59 | 906.05 | 2,454.9 | 1,051.4 | 1,057.55 | 1,129.22 | 857.82 | 662.44 | 631.1 | 483.32 |
Total Current Assets | 7,239.12 | 9,964.98 | 9,835.1 | 12,206.97 | 11,288.28 | 10,408.32 | 8,981.18 | 6,903.33 | 7,774.48 | 6,348.44 |
Current Liabilities | 2,285.86 | 2,396.31 | 2,243.3 | 2,539.03 | 2,526.66 | 2,120.15 | 1,960.64 | 1,450.46 | 1,456.07 | 1,262.6 |
Provisions | 119.65 | 122.09 | 103.36 | 250.01 | 115.27 | 96.51 | 74.54 | 61.5 | 56.95 | 86.02 |
Total Current Liabilities & Provisions | 2,405.51 | 2,518.4 | 2,346.66 | 2,789.04 | 2,641.93 | 2,216.66 | 2,035.18 | 1,511.96 | 1,513.02 | 1,348.62 |
Net Current Assets | 4,833.61 | 7,446.58 | 7,488.44 | 9,417.93 | 8,646.35 | 8,191.66 | 6,946 | 5,391.37 | 6,261.46 | 4,999.82 |
Deferred Tax Assets | 47.45 | 55.24 | 43.82 | 68.61 | 411.92 | 439.87 | 382.06 | 333.52 | 267.97 | 28.55 |
Deferred Tax Liability | 166.36 | 271.15 | 280.85 | 501.99 | 496.96 | 470.87 | 405.54 | 333.44 | 261.11 | 238.89 |
Net Deferred Tax | -118.91 | -215.91 | -237.03 | -433.38 | -85.04 | -31 | -23.48 | 0.08 | 6.86 | -210.34 |
Other Assets | 1,969.61 | 3,061.87 | 1,370.51 | 765.13 | 515.27 | 454.63 | 308.21 | 318.96 | 290.6 | 447.49 |
Total Assets | 22,629.56 | 22,324.5 | 19,017.26 | 19,966.57 | 16,836.64 | 15,893.06 | 13,735.18 | 11,510.96 | 11,052.54 | 8,666.92 |
Contingent Liabilities | 1,969.15 | 534.26 | 152.93 | 770.1 | 2,006.56 | 2,496.37 | 1,214.54 | 427.41 | 799.8 | 558.92 |
Cash Flow (Figures in Rs. Crores)
Net Profit before Tax and Extr... | 4,379.99 |
Depreciation | 1,521.66 |
Interest (Net) | -17.67 |
P/L on Sales of Assets | -23.49 |
P/L on Sales of Invest | -0.1 |
Prov. and W/O (Net) | 52.53 |
P/L in Forex | -51.14 |
Total Adjustments (PBT and Ext... | 1,496.24 |
Operating Profit before Workin... | 5,876.23 |
Trade and 0ther Receivables | -264.19 |
Inventories | -1,303.68 |
Trade Payables | 582.84 |
Loans and Advances | -0.69 |
Total Adjustments (OP before W... | -1,675.07 |
Cash Generated from/(used in) ... | 4,201.16 |
Direct Taxes Paid | -1,766.64 |
Total Adjustments(Cash Generat... | -1,766.64 |
Cash Flow before Extraordinary... | 2,434.52 |
Net Cash from Operating Activi... | 2,434.52 |
Purchased of Fixed Assets | -3,561.5 |
Sale of Fixed Assets | 60.28 |
Purchase of Investments | -25.7 |
Sale of Investments | 179.15 |
Interest Received | 280.84 |
Net Cash used in Investing Act... | -4,241.78 |
Proceed from 0ther Long Term B... | 1,563.24 |
Of the Long Tem Borrowings | -17.17 |
Of the Short Term Borrowings | -84.76 |
Of Financial Liabilities | -146.6 |
Dividend Paid | -263.64 |
Interest Paid | -250.65 |
Net Cash used in Financing Act... | 800.42 |
Net Profit before Tax and Extr... | 2,475.41 |
Depreciation | 348.66 |
Interest (Net) | -15.89 |
Dividend Received | 264.67 |
P/L on Sales of Assets | -1.43 |
P/L on Sales of Invest | 30.07 |
Prov. and W/O (Net) | 11.11 |
P/L in Forex | -38.11 |
Total Adjustments (PBT and Ext... | 69.61 |
Operating Profit before Workin... | 2,545.02 |
Trade and 0ther Receivables | -743.59 |
Inventories | -308.34 |
Trade Payables | 751.9 |
Loans and Advances | -1.11 |
Total Adjustments (OP before W... | -228.04 |
Cash Generated from/(used in) ... | 2,316.98 |
Direct Taxes Paid | -602.18 |
Total Adjustments(Cash Generat... | -602.18 |
Cash Flow before Extraordinary... | 1,714.8 |
Net Cash from Operating Activi... | 1,714.8 |
Purchased of Fixed Assets | -426.75 |
Sale of Fixed Assets | 4.68 |
Purchase of Investments | -3,932.05 |
Sale of Investments | 11.92 |
Interest Received | 199.51 |
Loans to Subsidiaires | -2,345.35 |
Net Cash used in Investing Act... | -151.58 |
Of the Short Term Borrowings | -1,341.96 |
Of Financial Liabilities | -21.71 |
Dividend Paid | -263.64 |
Interest Paid | -209.72 |
Net Cash used in Financing Act... | -1,837.03 |
Company Details
Registered Office |
|
Address | Plot No 2 Maitrivihar, Behind Maithri Vanam Ameerpet |
City | Hyderabad |
State | Telangana |
Pin Code | 500038 |
Tel. No. | 91-40-23736370 |
Fax. No. | 91-40-23747340 |
cs@aurobindo.com; investorgrievances@aurobindo.com | |
Internet | http://www.aurobindo.com |
Registrars |
|
Address | Plot No 2 Maitrivihar |
City | Hyderabad |
State | Telangana |
Pin Code | 500038 |
Tel. No. | 91-40-23736370 |
Fax. No. | 91-40-23747340 |
cs@aurobindo.com; investorgrievances@aurobindo.com | |
Internet | http://www.aurobindo.com |
Management |
|
Name | Designation |
Kambam Nityananda Reddy | Vice Chairman & M.D. |
M Madan Mohan Reddy | Whole-time Director |
P V Ramprasad Reddy | Non Executive Director |
Savita Mahajan | Independent Director |
Girish Paman Vanvari | Independent Director |
P Sarath Chandra Reddy | Non Executive Director |
Santanu Mukherjee | Independent Director |
Deepali Pant Joshi | Independent Director |
M R Kumar | Chairman & Independent Directo |
Satakarni Makkapati | Non Executive Director |